← All indications
Eclampsia
Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
Drugs by status
Approved for this indication (2)
Phase 4 trials (4)
Organizations
Organization Involved with Phase 4 Indications (21)
- Maastricht University
- Ain Shams University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Harvard University
- Duke University
- Guangzhou Medical University
- Kocaeli University
- University of Michigan
- University of New Mexico
- Assiut University
- Istanbul University
- Laval University
- Royal College of Surgeons, Ireland
- Stony Brook University
- University of Toulouse
- Louisiana State University
- Instituto de Medicina Integral Professor Fernando Figueira
- National Maternity Hospital, Ireland
- National University of Ireland
- Perinatal Ireland
- Institute of Arthritis Research
Organization Involved with Phase 3 Indications (44)
- Gynuity Health Projects
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Complejo Hospitalario Dr. Arnulfo Arias Madrid
- Baylor University
- Benha University
- Cairo University
- Case Western Reserve University
- Centre Hospitalier Intercommunal Creteil
- University of London
- Dow University of Health Sciences
- Federal University of Rio Grande do Sul
- Hawaii Pacific Health
- Oregon Health and Science University
- RTI International
- Services Institute of Medical Sciences, Pakistan
- University of Liverpool
- University of Tennessee
- University of Valencia
- Tel Aviv University
- University of Cincinnati
- University of Campinas
- University of Strasbourg
- Caja de seguro Social
- Hebrew University
- Government Dental College & Hospital, Aurangabad
- assistant profossor
- Complejo Hospitalario Caja de Seguro social
- +14 more
Organization Involved with Phase 2 Indications (15)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (21)
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Aarhus University
- Gadarif University
- Jawaharlal Nehru Medical College
- Stanford University
- Aga Khan University
- Chinese University of Hong Kong
- Municipal Hospital Vila Nova Cachoeirinha
- University of British Columbia
- University of Utah
- Icahn School of Medicine at Mount Sinai
- Food and Drug Administration
- John Snow, Inc.
- Technion University
- Maternidade Escola de Vila Nova Cachoeirinha
- University of Mississippi
- Rajavithi Hospital, Bangkok
- Olabisi Onabanjo University
- Government of Mozambique
- Alex Ekwueme Federal University Teaching Hospital